The two companies have partnered for 15 years, combining Arkema’s expertise and intellectual property in PEKK technology together with SEQENS’ recognized know-how in the production of polymers for the pharmaceutical and life sciences markets.
PEKK is a high-performance polymer family used in aerospace and other demanding markets, commercialized by Arkema under the Kepstan trademark. SEQENS’ IMPEKK materials have been specifically developed for long term medical implantable applications and could represent an alternative to existing titanium and PEEK materials. IMPEKK materials will be provided to the market by SEQENS through a global network of partners, including well-known manufacturers, 3D printing machine companies, and distributors.